nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ABCB1—colon cancer	0.297	1	CbGaD
Desipramine—SLC22A3—Irinotecan—colon cancer	0.136	0.297	CbGbCtD
Desipramine—SLC22A3—Vincristine—colon cancer	0.119	0.26	CbGbCtD
Desipramine—CYP2A6—Fluorouracil—colon cancer	0.0615	0.135	CbGbCtD
Desipramine—CYP2B6—Irinotecan—colon cancer	0.0417	0.0914	CbGbCtD
Desipramine—CYP1A2—Fluorouracil—colon cancer	0.0235	0.0514	CbGbCtD
Desipramine—ABCB1—Irinotecan—colon cancer	0.0214	0.0468	CbGbCtD
Desipramine—ABCB1—Vincristine—colon cancer	0.0187	0.0409	CbGbCtD
Desipramine—CYP3A4—Irinotecan—colon cancer	0.0128	0.0281	CbGbCtD
Desipramine—ABCB1—Methotrexate—colon cancer	0.0113	0.0248	CbGbCtD
Desipramine—CYP3A4—Vincristine—colon cancer	0.0112	0.0245	CbGbCtD
Desipramine—CHRM3—ureter—colon cancer	0.0102	0.107	CbGeAlD
Desipramine—ORM1—bile—colon cancer	0.00804	0.0839	CbGeAlD
Desipramine—CHRM3—muscle of abdomen—colon cancer	0.00737	0.0769	CbGeAlD
Desipramine—HTR2A—myenteric nerve plexus—colon cancer	0.00523	0.0546	CbGeAlD
Desipramine—HTR2A—vein—colon cancer	0.00337	0.0352	CbGeAlD
Desipramine—Paresthesia of limbs—Methotrexate—colon cancer	0.00319	0.0271	CcSEcCtD
Desipramine—Ileus paralytic—Vincristine—colon cancer	0.00291	0.0248	CcSEcCtD
Desipramine—Sudden death—Irinotecan—colon cancer	0.0024	0.0204	CcSEcCtD
Desipramine—Sudden death—Fluorouracil—colon cancer	0.00229	0.0195	CcSEcCtD
Desipramine—ORM1—gall bladder—colon cancer	0.00223	0.0233	CbGeAlD
Desipramine—SMPD1—renal system—colon cancer	0.00219	0.0228	CbGeAlD
Desipramine—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.00217	0.0184	CcSEcCtD
Desipramine—Ileus paralytic—Capecitabine—colon cancer	0.0019	0.0161	CcSEcCtD
Desipramine—Abdominal cramps—Vincristine—colon cancer	0.00186	0.0159	CcSEcCtD
Desipramine—SMPD1—lymphoid tissue—colon cancer	0.00182	0.019	CbGeAlD
Desipramine—Abdominal cramps—Irinotecan—colon cancer	0.00182	0.0155	CcSEcCtD
Desipramine—SMPD1—digestive system—colon cancer	0.00179	0.0187	CbGeAlD
Desipramine—Sudden death—Capecitabine—colon cancer	0.0016	0.0136	CcSEcCtD
Desipramine—SMPD1—vagina—colon cancer	0.00158	0.0165	CbGeAlD
Desipramine—CHRM5—epithelium—colon cancer	0.00157	0.0164	CbGeAlD
Desipramine—Numbness—Vincristine—colon cancer	0.00152	0.0129	CcSEcCtD
Desipramine—Tingling sensation—Fluorouracil—colon cancer	0.00146	0.0124	CcSEcCtD
Desipramine—CYP2C18—digestive system—colon cancer	0.00146	0.0152	CbGeAlD
Desipramine—Sensory loss—Vincristine—colon cancer	0.00145	0.0124	CcSEcCtD
Desipramine—Numbness—Fluorouracil—colon cancer	0.00142	0.0121	CcSEcCtD
Desipramine—SLC22A2—renal system—colon cancer	0.00139	0.0145	CbGeAlD
Desipramine—Sensory loss—Fluorouracil—colon cancer	0.00136	0.0115	CcSEcCtD
Desipramine—SMPD1—liver—colon cancer	0.00134	0.0139	CbGeAlD
Desipramine—Raised liver function tests—Methotrexate—colon cancer	0.00132	0.0113	CcSEcCtD
Desipramine—CYP2C18—vagina—colon cancer	0.00129	0.0135	CbGeAlD
Desipramine—SLC22A3—embryo—colon cancer	0.00124	0.0129	CbGeAlD
Desipramine—Phosphatase alkaline increased—Irinotecan—colon cancer	0.00123	0.0104	CcSEcCtD
Desipramine—Sudden death—Methotrexate—colon cancer	0.00119	0.0102	CcSEcCtD
Desipramine—HTR2A—endothelium—colon cancer	0.00116	0.0121	CbGeAlD
Desipramine—SLC22A2—digestive system—colon cancer	0.00114	0.0119	CbGeAlD
Desipramine—CYP2C18—liver—colon cancer	0.00109	0.0113	CbGeAlD
Desipramine—Ventricular fibrillation—Capecitabine—colon cancer	0.00107	0.00912	CcSEcCtD
Desipramine—HTR2A—blood vessel—colon cancer	0.00107	0.0112	CbGeAlD
Desipramine—SLC22A4—renal system—colon cancer	0.00103	0.0108	CbGeAlD
Desipramine—SMPD1—lymph node—colon cancer	0.00102	0.0107	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00102	0.00871	CcSEcCtD
Desipramine—Tingling sensation—Capecitabine—colon cancer	0.00102	0.00869	CcSEcCtD
Desipramine—Petechiae—Capecitabine—colon cancer	0.000997	0.00849	CcSEcCtD
Desipramine—SLC22A1—renal system—colon cancer	0.000981	0.0102	CbGeAlD
Desipramine—SLC22A3—smooth muscle tissue—colon cancer	0.000974	0.0102	CbGeAlD
Desipramine—Disorientation—Fluorouracil—colon cancer	0.000953	0.00811	CcSEcCtD
Desipramine—SLC22A3—renal system—colon cancer	0.000938	0.00979	CbGeAlD
Desipramine—Ventricular extrasystoles—Capecitabine—colon cancer	0.000908	0.00773	CcSEcCtD
Desipramine—Cerebrovascular accident—Irinotecan—colon cancer	0.000908	0.00773	CcSEcCtD
Desipramine—Nocturia—Capecitabine—colon cancer	0.000884	0.00753	CcSEcCtD
Desipramine—Urinary retention—Vincristine—colon cancer	0.000869	0.00739	CcSEcCtD
Desipramine—Ataxia—Vincristine—colon cancer	0.000859	0.00731	CcSEcCtD
Desipramine—CYP2A6—vagina—colon cancer	0.000852	0.00889	CbGeAlD
Desipramine—CHRM3—smooth muscle tissue—colon cancer	0.000845	0.00882	CbGeAlD
Desipramine—SLC22A4—digestive system—colon cancer	0.000845	0.00882	CbGeAlD
Desipramine—Coordination abnormal—Capecitabine—colon cancer	0.000835	0.00711	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00082	0.00698	CcSEcCtD
Desipramine—CHRM3—renal system—colon cancer	0.000814	0.00849	CbGeAlD
Desipramine—HTR1A—renal system—colon cancer	0.000811	0.00846	CbGeAlD
Desipramine—ORM1—bone marrow—colon cancer	0.00081	0.00845	CbGeAlD
Desipramine—Ataxia—Fluorouracil—colon cancer	0.000801	0.00682	CcSEcCtD
Desipramine—SLC22A4—bone marrow—colon cancer	0.000779	0.00813	CbGeAlD
Desipramine—SLC6A4—digestive system—colon cancer	0.000749	0.00781	CbGeAlD
Desipramine—SLC22A4—vagina—colon cancer	0.000747	0.00779	CbGeAlD
Desipramine—Petechiae—Methotrexate—colon cancer	0.000742	0.00632	CcSEcCtD
Desipramine—Eosinophilia—Fluorouracil—colon cancer	0.000729	0.00621	CcSEcCtD
Desipramine—Erectile dysfunction—Vincristine—colon cancer	0.000727	0.00619	CcSEcCtD
Desipramine—CYP2A6—liver—colon cancer	0.000719	0.0075	CbGeAlD
Desipramine—SLC22A1—vagina—colon cancer	0.000711	0.00742	CbGeAlD
Desipramine—Depression—Vincristine—colon cancer	0.000702	0.00598	CcSEcCtD
Desipramine—ABCB1—blood vessel—colon cancer	0.000701	0.00732	CbGeAlD
Desipramine—Acute coronary syndrome—Vincristine—colon cancer	0.000694	0.00591	CcSEcCtD
Desipramine—Neuropathy peripheral—Vincristine—colon cancer	0.00069	0.00587	CcSEcCtD
Desipramine—Myocardial infarction—Vincristine—colon cancer	0.00069	0.00587	CcSEcCtD
Desipramine—Stomatitis—Vincristine—colon cancer	0.000686	0.00584	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000685	0.00583	CcSEcCtD
Desipramine—SLC22A5—renal system—colon cancer	0.000682	0.00712	CbGeAlD
Desipramine—SLC22A3—vagina—colon cancer	0.000679	0.00709	CbGeAlD
Desipramine—Acute coronary syndrome—Irinotecan—colon cancer	0.000676	0.00575	CcSEcCtD
Desipramine—Myocardial infarction—Irinotecan—colon cancer	0.000672	0.00572	CcSEcCtD
Desipramine—Jaundice—Irinotecan—colon cancer	0.000668	0.00569	CcSEcCtD
Desipramine—Stomatitis—Irinotecan—colon cancer	0.000668	0.00569	CcSEcCtD
Desipramine—CHRM3—digestive system—colon cancer	0.000668	0.00697	CbGeAlD
Desipramine—Vascular purpura—Capecitabine—colon cancer	0.000666	0.00567	CcSEcCtD
Desipramine—ORM1—liver—colon cancer	0.000655	0.00683	CbGeAlD
Desipramine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000647	0.00551	CcSEcCtD
Desipramine—Myocardial infarction—Fluorouracil—colon cancer	0.000644	0.00548	CcSEcCtD
Desipramine—Neuropathy peripheral—Fluorouracil—colon cancer	0.000644	0.00548	CcSEcCtD
Desipramine—Libido decreased—Capecitabine—colon cancer	0.000642	0.00547	CcSEcCtD
Desipramine—Stomatitis—Fluorouracil—colon cancer	0.00064	0.00545	CcSEcCtD
Desipramine—HTR2A—embryo—colon cancer	0.000638	0.00666	CbGeAlD
Desipramine—Hallucination—Vincristine—colon cancer	0.000629	0.00535	CcSEcCtD
Desipramine—Hypoaesthesia—Vincristine—colon cancer	0.000629	0.00535	CcSEcCtD
Desipramine—HRH1—epithelium—colon cancer	0.000624	0.00651	CbGeAlD
Desipramine—CYP2C19—digestive system—colon cancer	0.00062	0.00647	CbGeAlD
Desipramine—Purpura—Capecitabine—colon cancer	0.000618	0.00526	CcSEcCtD
Desipramine—CYP1A2—renal system—colon cancer	0.000618	0.00645	CbGeAlD
Desipramine—Agranulocytosis—Fluorouracil—colon cancer	0.000613	0.00522	CcSEcCtD
Desipramine—Cerebrovascular accident—Capecitabine—colon cancer	0.000608	0.00517	CcSEcCtD
Desipramine—HRH1—smooth muscle tissue—colon cancer	0.000601	0.00627	CbGeAlD
Desipramine—SLC22A1—liver—colon cancer	0.0006	0.00626	CbGeAlD
Desipramine—CYP2B6—renal system—colon cancer	0.000592	0.00618	CbGeAlD
Desipramine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000591	0.00503	CcSEcCtD
Desipramine—Hypoaesthesia—Fluorouracil—colon cancer	0.000587	0.00499	CcSEcCtD
Desipramine—SLC22A3—liver—colon cancer	0.000573	0.00598	CbGeAlD
Desipramine—Flushing—Irinotecan—colon cancer	0.000571	0.00486	CcSEcCtD
Desipramine—Urinary retention—Capecitabine—colon cancer	0.000566	0.00482	CcSEcCtD
Desipramine—Ataxia—Capecitabine—colon cancer	0.00056	0.00477	CcSEcCtD
Desipramine—SLC22A5—digestive system—colon cancer	0.000559	0.00584	CbGeAlD
Desipramine—Alopecia—Vincristine—colon cancer	0.000559	0.00475	CcSEcCtD
Desipramine—CYP2E1—renal system—colon cancer	0.000556	0.0058	CbGeAlD
Desipramine—Arrhythmia—Irinotecan—colon cancer	0.00055	0.00468	CcSEcCtD
Desipramine—Liver function test abnormal—Capecitabine—colon cancer	0.00055	0.00468	CcSEcCtD
Desipramine—CYP2C19—vagina—colon cancer	0.000548	0.00572	CbGeAlD
Desipramine—Gynaecomastia—Methotrexate—colon cancer	0.000546	0.00465	CcSEcCtD
Desipramine—Alopecia—Irinotecan—colon cancer	0.000544	0.00463	CcSEcCtD
Desipramine—Arrhythmia—Fluorouracil—colon cancer	0.000527	0.00448	CcSEcCtD
Desipramine—Alopecia—Fluorouracil—colon cancer	0.000521	0.00443	CcSEcCtD
Desipramine—HTR2A—epithelium—colon cancer	0.000521	0.00543	CbGeAlD
Desipramine—CYP1A2—digestive system—colon cancer	0.000507	0.00529	CbGeAlD
Desipramine—Agitation—Vincristine—colon cancer	0.000506	0.0043	CcSEcCtD
Desipramine—ORM1—lymph node—colon cancer	0.000502	0.00524	CbGeAlD
Desipramine—HTR2A—smooth muscle tissue—colon cancer	0.000502	0.00524	CbGeAlD
Desipramine—Ill-defined disorder—Irinotecan—colon cancer	0.000497	0.00423	CcSEcCtD
Desipramine—SLC22A5—vagina—colon cancer	0.000494	0.00515	CbGeAlD
Desipramine—CYP2B6—lymphoid tissue—colon cancer	0.000492	0.00513	CbGeAlD
Desipramine—CYP2B6—digestive system—colon cancer	0.000486	0.00507	CbGeAlD
Desipramine—Vision blurred—Fluorouracil—colon cancer	0.000484	0.00412	CcSEcCtD
Desipramine—Malaise—Irinotecan—colon cancer	0.000483	0.00411	CcSEcCtD
Desipramine—HTR2A—renal system—colon cancer	0.000483	0.00504	CbGeAlD
Desipramine—SLC22A4—lymph node—colon cancer	0.000483	0.00504	CbGeAlD
Desipramine—Convulsion—Vincristine—colon cancer	0.000477	0.00406	CcSEcCtD
Desipramine—Hypertension—Vincristine—colon cancer	0.000475	0.00404	CcSEcCtD
Desipramine—HRH1—digestive system—colon cancer	0.000474	0.00495	CbGeAlD
Desipramine—Weight increased—Capecitabine—colon cancer	0.000468	0.00399	CcSEcCtD
Desipramine—Hypertension—Irinotecan—colon cancer	0.000463	0.00394	CcSEcCtD
Desipramine—CYP2C19—liver—colon cancer	0.000462	0.00482	CbGeAlD
Desipramine—CYP2E1—lymphoid tissue—colon cancer	0.000462	0.00482	CbGeAlD
Desipramine—Depression—Capecitabine—colon cancer	0.000458	0.00389	CcSEcCtD
Desipramine—CYP2E1—digestive system—colon cancer	0.000456	0.00476	CbGeAlD
Desipramine—Acute coronary syndrome—Capecitabine—colon cancer	0.000452	0.00385	CcSEcCtD
Desipramine—Cerebrovascular accident—Methotrexate—colon cancer	0.000452	0.00385	CcSEcCtD
Desipramine—Discomfort—Irinotecan—colon cancer	0.000451	0.00384	CcSEcCtD
Desipramine—Myocardial infarction—Capecitabine—colon cancer	0.00045	0.00383	CcSEcCtD
Desipramine—Neuropathy peripheral—Capecitabine—colon cancer	0.00045	0.00383	CcSEcCtD
Desipramine—Oedema—Vincristine—colon cancer	0.000449	0.00382	CcSEcCtD
Desipramine—Stomatitis—Capecitabine—colon cancer	0.000447	0.00381	CcSEcCtD
Desipramine—Jaundice—Capecitabine—colon cancer	0.000447	0.00381	CcSEcCtD
Desipramine—CYP3A4—renal system—colon cancer	0.000447	0.00467	CbGeAlD
Desipramine—Convulsion—Fluorouracil—colon cancer	0.000445	0.00378	CcSEcCtD
Desipramine—Confusional state—Irinotecan—colon cancer	0.000441	0.00375	CcSEcCtD
Desipramine—CYP2D6—renal system—colon cancer	0.00044	0.00459	CbGeAlD
Desipramine—Thrombocytopenia—Vincristine—colon cancer	0.00044	0.00374	CcSEcCtD
Desipramine—SLC22A3—lymph node—colon cancer	0.000439	0.00459	CbGeAlD
Desipramine—Protriptyline—ABCB1—colon cancer	0.000438	0.177	CrCbGaD
Desipramine—Oedema—Irinotecan—colon cancer	0.000437	0.00372	CcSEcCtD
Desipramine—Discomfort—Fluorouracil—colon cancer	0.000432	0.00367	CcSEcCtD
Desipramine—CYP2B6—vagina—colon cancer	0.000429	0.00448	CbGeAlD
Desipramine—Agranulocytosis—Capecitabine—colon cancer	0.000428	0.00365	CcSEcCtD
Desipramine—Thrombocytopenia—Irinotecan—colon cancer	0.000428	0.00364	CcSEcCtD
Desipramine—Anorexia—Vincristine—colon cancer	0.000428	0.00364	CcSEcCtD
Desipramine—Confusional state—Fluorouracil—colon cancer	0.000422	0.00359	CcSEcCtD
Desipramine—Hypotension—Vincristine—colon cancer	0.00042	0.00357	CcSEcCtD
Desipramine—HRH1—vagina—colon cancer	0.000419	0.00437	CbGeAlD
Desipramine—Oedema—Fluorouracil—colon cancer	0.000419	0.00357	CcSEcCtD
Desipramine—ABCB1—embryo—colon cancer	0.000418	0.00436	CbGeAlD
Desipramine—Anorexia—Irinotecan—colon cancer	0.000417	0.00355	CcSEcCtD
Desipramine—Ataxia—Methotrexate—colon cancer	0.000417	0.00355	CcSEcCtD
Desipramine—SLC22A5—liver—colon cancer	0.000417	0.00435	CbGeAlD
Desipramine—Hepatitis—Capecitabine—colon cancer	0.000412	0.00351	CcSEcCtD
Desipramine—Thrombocytopenia—Fluorouracil—colon cancer	0.00041	0.00349	CcSEcCtD
Desipramine—Hypoaesthesia—Capecitabine—colon cancer	0.00041	0.00349	CcSEcCtD
Desipramine—Liver function test abnormal—Methotrexate—colon cancer	0.000409	0.00348	CcSEcCtD
Desipramine—Tachycardia—Fluorouracil—colon cancer	0.000409	0.00348	CcSEcCtD
Desipramine—Hypotension—Irinotecan—colon cancer	0.000409	0.00348	CcSEcCtD
Desipramine—Insomnia—Vincristine—colon cancer	0.000406	0.00346	CcSEcCtD
Desipramine—Paraesthesia—Vincristine—colon cancer	0.000403	0.00343	CcSEcCtD
Desipramine—Anorexia—Fluorouracil—colon cancer	0.000399	0.0034	CcSEcCtD
Desipramine—HTR2A—digestive system—colon cancer	0.000396	0.00413	CbGeAlD
Desipramine—Insomnia—Irinotecan—colon cancer	0.000396	0.00337	CcSEcCtD
Desipramine—Paraesthesia—Irinotecan—colon cancer	0.000393	0.00334	CcSEcCtD
Desipramine—Hypotension—Fluorouracil—colon cancer	0.000391	0.00333	CcSEcCtD
Desipramine—Decreased appetite—Vincristine—colon cancer	0.00039	0.00332	CcSEcCtD
Desipramine—Somnolence—Irinotecan—colon cancer	0.000389	0.00331	CcSEcCtD
Desipramine—Fatigue—Vincristine—colon cancer	0.000387	0.0033	CcSEcCtD
Desipramine—Dyspepsia—Irinotecan—colon cancer	0.000385	0.00328	CcSEcCtD
Desipramine—Tinnitus—Capecitabine—colon cancer	0.000384	0.00327	CcSEcCtD
Desipramine—Constipation—Vincristine—colon cancer	0.000384	0.00327	CcSEcCtD
Desipramine—Flushing—Capecitabine—colon cancer	0.000382	0.00325	CcSEcCtD
Desipramine—Decreased appetite—Irinotecan—colon cancer	0.00038	0.00324	CcSEcCtD
Desipramine—Eosinophilia—Methotrexate—colon cancer	0.000379	0.00323	CcSEcCtD
Desipramine—Insomnia—Fluorouracil—colon cancer	0.000379	0.00322	CcSEcCtD
Desipramine—CYP1A2—liver—colon cancer	0.000378	0.00394	CbGeAlD
Desipramine—Fatigue—Irinotecan—colon cancer	0.000377	0.00321	CcSEcCtD
Desipramine—SLC6A2—lymph node—colon cancer	0.000377	0.00393	CbGeAlD
Desipramine—Paraesthesia—Fluorouracil—colon cancer	0.000376	0.0032	CcSEcCtD
Desipramine—Constipation—Irinotecan—colon cancer	0.000374	0.00318	CcSEcCtD
Desipramine—Somnolence—Fluorouracil—colon cancer	0.000372	0.00317	CcSEcCtD
Desipramine—Dyspepsia—Fluorouracil—colon cancer	0.000369	0.00314	CcSEcCtD
Desipramine—Arrhythmia—Capecitabine—colon cancer	0.000368	0.00313	CcSEcCtD
Desipramine—CYP3A4—digestive system—colon cancer	0.000367	0.00383	CbGeAlD
Desipramine—Decreased appetite—Fluorouracil—colon cancer	0.000364	0.0031	CcSEcCtD
Desipramine—Alopecia—Capecitabine—colon cancer	0.000364	0.0031	CcSEcCtD
Desipramine—CYP2B6—liver—colon cancer	0.000362	0.00378	CbGeAlD
Desipramine—CYP2D6—digestive system—colon cancer	0.000361	0.00377	CbGeAlD
Desipramine—Feeling abnormal—Irinotecan—colon cancer	0.00036	0.00307	CcSEcCtD
Desipramine—Body temperature increased—Vincristine—colon cancer	0.000355	0.00302	CcSEcCtD
Desipramine—Abdominal pain—Vincristine—colon cancer	0.000355	0.00302	CcSEcCtD
Desipramine—Erectile dysfunction—Methotrexate—colon cancer	0.000353	0.003	CcSEcCtD
Desipramine—Dysgeusia—Capecitabine—colon cancer	0.000351	0.00299	CcSEcCtD
Desipramine—HTR2A—vagina—colon cancer	0.00035	0.00365	CbGeAlD
Desipramine—Abdominal pain—Irinotecan—colon cancer	0.000346	0.00294	CcSEcCtD
Desipramine—Body temperature increased—Irinotecan—colon cancer	0.000346	0.00294	CcSEcCtD
Desipramine—Feeling abnormal—Fluorouracil—colon cancer	0.000345	0.00294	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—colon cancer	0.000342	0.00291	CcSEcCtD
Desipramine—ABCB1—epithelium—colon cancer	0.000341	0.00356	CbGeAlD
Desipramine—Depression—Methotrexate—colon cancer	0.000341	0.0029	CcSEcCtD
Desipramine—CYP2E1—liver—colon cancer	0.00034	0.00354	CbGeAlD
Desipramine—Vision blurred—Capecitabine—colon cancer	0.000338	0.00288	CcSEcCtD
Desipramine—Tremor—Capecitabine—colon cancer	0.000336	0.00286	CcSEcCtD
Desipramine—Stomatitis—Methotrexate—colon cancer	0.000333	0.00283	CcSEcCtD
Desipramine—Ill-defined disorder—Capecitabine—colon cancer	0.000333	0.00283	CcSEcCtD
Desipramine—Urticaria—Fluorouracil—colon cancer	0.000333	0.00283	CcSEcCtD
Desipramine—Body temperature increased—Fluorouracil—colon cancer	0.000331	0.00282	CcSEcCtD
Desipramine—Epinastine—ABCB1—colon cancer	0.000324	0.131	CrCbGaD
Desipramine—Malaise—Capecitabine—colon cancer	0.000323	0.00275	CcSEcCtD
Desipramine—Asthenia—Vincristine—colon cancer	0.000322	0.00274	CcSEcCtD
Desipramine—SLC22A5—lymph node—colon cancer	0.00032	0.00333	CbGeAlD
Desipramine—Agranulocytosis—Methotrexate—colon cancer	0.000319	0.00271	CcSEcCtD
Desipramine—Palpitations—Capecitabine—colon cancer	0.000317	0.0027	CcSEcCtD
Desipramine—ABCB1—renal system—colon cancer	0.000317	0.0033	CbGeAlD
Desipramine—Asthenia—Irinotecan—colon cancer	0.000314	0.00267	CcSEcCtD
Desipramine—Hypertension—Capecitabine—colon cancer	0.00031	0.00264	CcSEcCtD
Desipramine—Diarrhoea—Vincristine—colon cancer	0.000307	0.00262	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—colon cancer	0.000307	0.00261	CcSEcCtD
Desipramine—Anxiety—Capecitabine—colon cancer	0.000304	0.00259	CcSEcCtD
Desipramine—Discomfort—Capecitabine—colon cancer	0.000302	0.00257	CcSEcCtD
Desipramine—Diarrhoea—Irinotecan—colon cancer	0.000299	0.00255	CcSEcCtD
Desipramine—Dry mouth—Capecitabine—colon cancer	0.000299	0.00254	CcSEcCtD
Desipramine—Dizziness—Vincristine—colon cancer	0.000297	0.00253	CcSEcCtD
Desipramine—Pruritus—Fluorouracil—colon cancer	0.000296	0.00252	CcSEcCtD
Desipramine—HTR2A—liver—colon cancer	0.000295	0.00308	CbGeAlD
Desipramine—Confusional state—Capecitabine—colon cancer	0.000295	0.00251	CcSEcCtD
Desipramine—Oedema—Capecitabine—colon cancer	0.000293	0.00249	CcSEcCtD
Desipramine—Dizziness—Irinotecan—colon cancer	0.000289	0.00246	CcSEcCtD
Desipramine—Diarrhoea—Fluorouracil—colon cancer	0.000287	0.00244	CcSEcCtD
Desipramine—Thrombocytopenia—Capecitabine—colon cancer	0.000287	0.00244	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—colon cancer	0.000286	0.00243	CcSEcCtD
Desipramine—Tachycardia—Capecitabine—colon cancer	0.000286	0.00243	CcSEcCtD
Desipramine—Vomiting—Vincristine—colon cancer	0.000286	0.00243	CcSEcCtD
Desipramine—Rash—Vincristine—colon cancer	0.000283	0.00241	CcSEcCtD
Desipramine—Dermatitis—Vincristine—colon cancer	0.000283	0.00241	CcSEcCtD
Desipramine—Headache—Vincristine—colon cancer	0.000281	0.00239	CcSEcCtD
Desipramine—Maprotiline—ABCB1—colon cancer	0.000279	0.113	CrCbGaD
Desipramine—Anorexia—Capecitabine—colon cancer	0.000279	0.00237	CcSEcCtD
Desipramine—Vomiting—Irinotecan—colon cancer	0.000278	0.00237	CcSEcCtD
Desipramine—Dizziness—Fluorouracil—colon cancer	0.000277	0.00236	CcSEcCtD
Desipramine—Rash—Irinotecan—colon cancer	0.000276	0.00235	CcSEcCtD
Desipramine—Dermatitis—Irinotecan—colon cancer	0.000276	0.00234	CcSEcCtD
Desipramine—Headache—Irinotecan—colon cancer	0.000274	0.00233	CcSEcCtD
Desipramine—Hypotension—Capecitabine—colon cancer	0.000274	0.00233	CcSEcCtD
Desipramine—CYP3A4—liver—colon cancer	0.000273	0.00285	CbGeAlD
Desipramine—Alopecia—Methotrexate—colon cancer	0.000271	0.00231	CcSEcCtD
Desipramine—HRH1—lymph node—colon cancer	0.000271	0.00283	CbGeAlD
Desipramine—CYP2D6—liver—colon cancer	0.000269	0.00281	CbGeAlD
Desipramine—Nausea—Vincristine—colon cancer	0.000267	0.00227	CcSEcCtD
Desipramine—Vomiting—Fluorouracil—colon cancer	0.000266	0.00227	CcSEcCtD
Desipramine—Insomnia—Capecitabine—colon cancer	0.000265	0.00225	CcSEcCtD
Desipramine—Rash—Fluorouracil—colon cancer	0.000264	0.00225	CcSEcCtD
Desipramine—Dermatitis—Fluorouracil—colon cancer	0.000264	0.00225	CcSEcCtD
Desipramine—ABCB1—lymphoid tissue—colon cancer	0.000263	0.00274	CbGeAlD
Desipramine—Paraesthesia—Capecitabine—colon cancer	0.000263	0.00224	CcSEcCtD
Desipramine—Headache—Fluorouracil—colon cancer	0.000262	0.00223	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—colon cancer	0.000261	0.00223	CcSEcCtD
Desipramine—Nausea—Irinotecan—colon cancer	0.00026	0.00221	CcSEcCtD
Desipramine—ABCB1—digestive system—colon cancer	0.00026	0.00271	CbGeAlD
Desipramine—Dyspepsia—Capecitabine—colon cancer	0.000258	0.00219	CcSEcCtD
Desipramine—Decreased appetite—Capecitabine—colon cancer	0.000254	0.00217	CcSEcCtD
Desipramine—Fatigue—Capecitabine—colon cancer	0.000252	0.00215	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—colon cancer	0.000252	0.00214	CcSEcCtD
Desipramine—Constipation—Capecitabine—colon cancer	0.00025	0.00213	CcSEcCtD
Desipramine—Nausea—Fluorouracil—colon cancer	0.000249	0.00212	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—colon cancer	0.000248	0.00211	CcSEcCtD
Desipramine—Triflupromazine—ABCB1—colon cancer	0.000244	0.0987	CrCbGaD
Desipramine—Feeling abnormal—Capecitabine—colon cancer	0.000241	0.00205	CcSEcCtD
Desipramine—Malaise—Methotrexate—colon cancer	0.000241	0.00205	CcSEcCtD
Desipramine—ABCB1—bone marrow—colon cancer	0.000239	0.0025	CbGeAlD
Desipramine—Urticaria—Capecitabine—colon cancer	0.000233	0.00198	CcSEcCtD
Desipramine—Body temperature increased—Capecitabine—colon cancer	0.000231	0.00197	CcSEcCtD
Desipramine—Abdominal pain—Capecitabine—colon cancer	0.000231	0.00197	CcSEcCtD
Desipramine—Convulsion—Methotrexate—colon cancer	0.000231	0.00197	CcSEcCtD
Desipramine—ABCB1—vagina—colon cancer	0.000229	0.00239	CbGeAlD
Desipramine—Discomfort—Methotrexate—colon cancer	0.000225	0.00191	CcSEcCtD
Desipramine—Confusional state—Methotrexate—colon cancer	0.00022	0.00187	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—colon cancer	0.000213	0.00182	CcSEcCtD
Desipramine—Asthenia—Capecitabine—colon cancer	0.00021	0.00179	CcSEcCtD
Desipramine—Anorexia—Methotrexate—colon cancer	0.000208	0.00177	CcSEcCtD
Desipramine—Pruritus—Capecitabine—colon cancer	0.000207	0.00176	CcSEcCtD
Desipramine—Carbamazepine—ABCB1—colon cancer	0.000204	0.0824	CrCbGaD
Desipramine—Hypotension—Methotrexate—colon cancer	0.000204	0.00173	CcSEcCtD
Desipramine—Diarrhoea—Capecitabine—colon cancer	0.0002	0.0017	CcSEcCtD
Desipramine—Insomnia—Methotrexate—colon cancer	0.000197	0.00168	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—colon cancer	0.000196	0.00167	CcSEcCtD
Desipramine—Somnolence—Methotrexate—colon cancer	0.000194	0.00165	CcSEcCtD
Desipramine—Dizziness—Capecitabine—colon cancer	0.000194	0.00165	CcSEcCtD
Desipramine—ABCB1—liver—colon cancer	0.000193	0.00202	CbGeAlD
Desipramine—Dyspepsia—Methotrexate—colon cancer	0.000192	0.00163	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—colon cancer	0.000189	0.00161	CcSEcCtD
Desipramine—Fatigue—Methotrexate—colon cancer	0.000188	0.0016	CcSEcCtD
Desipramine—Vomiting—Capecitabine—colon cancer	0.000186	0.00158	CcSEcCtD
Desipramine—Rash—Capecitabine—colon cancer	0.000185	0.00157	CcSEcCtD
Desipramine—Dermatitis—Capecitabine—colon cancer	0.000184	0.00157	CcSEcCtD
Desipramine—Headache—Capecitabine—colon cancer	0.000183	0.00156	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—colon cancer	0.00018	0.00153	CcSEcCtD
Desipramine—Nausea—Capecitabine—colon cancer	0.000174	0.00148	CcSEcCtD
Desipramine—Urticaria—Methotrexate—colon cancer	0.000173	0.00147	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—colon cancer	0.000172	0.00147	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—colon cancer	0.000172	0.00147	CcSEcCtD
Desipramine—Clomipramine—ABCB1—colon cancer	0.000172	0.0694	CrCbGaD
Desipramine—Trimipramine—ABCB1—colon cancer	0.000158	0.0639	CrCbGaD
Desipramine—Asthenia—Methotrexate—colon cancer	0.000156	0.00133	CcSEcCtD
Desipramine—Pruritus—Methotrexate—colon cancer	0.000154	0.00131	CcSEcCtD
Desipramine—Promethazine—ABCB1—colon cancer	0.000152	0.0615	CrCbGaD
Desipramine—Doxepin—ABCB1—colon cancer	0.00015	0.0609	CrCbGaD
Desipramine—Diarrhoea—Methotrexate—colon cancer	0.000149	0.00127	CcSEcCtD
Desipramine—ABCB1—lymph node—colon cancer	0.000148	0.00155	CbGeAlD
Desipramine—Dizziness—Methotrexate—colon cancer	0.000144	0.00123	CcSEcCtD
Desipramine—Vomiting—Methotrexate—colon cancer	0.000139	0.00118	CcSEcCtD
Desipramine—Rash—Methotrexate—colon cancer	0.000137	0.00117	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—colon cancer	0.000137	0.00117	CcSEcCtD
Desipramine—Headache—Methotrexate—colon cancer	0.000137	0.00116	CcSEcCtD
Desipramine—Nausea—Methotrexate—colon cancer	0.000129	0.0011	CcSEcCtD
Desipramine—Chlorpromazine—ABCB1—colon cancer	0.000118	0.0476	CrCbGaD
Desipramine—Imipramine—ABCB1—colon cancer	0.000117	0.0474	CrCbGaD
Desipramine—Amitriptyline—ABCB1—colon cancer	0.000116	0.0471	CrCbGaD
Desipramine—CYP1A2—Metabolism—TYMS—colon cancer	4.51e-06	0.000149	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CASP3—colon cancer	4.49e-06	0.000148	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CCND1—colon cancer	4.47e-06	0.000147	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—colon cancer	4.47e-06	0.000147	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CASP3—colon cancer	4.47e-06	0.000147	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—EP300—colon cancer	4.46e-06	0.000147	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFB1—colon cancer	4.46e-06	0.000147	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.45e-06	0.000147	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CTNNB1—colon cancer	4.43e-06	0.000146	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—PIK3CA—colon cancer	4.43e-06	0.000146	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CDKN1A—colon cancer	4.42e-06	0.000146	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—EP300—colon cancer	4.4e-06	0.000145	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CCND1—colon cancer	4.37e-06	0.000144	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—colon cancer	4.37e-06	0.000144	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—colon cancer	4.36e-06	0.000144	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—PIK3CA—colon cancer	4.35e-06	0.000144	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CCND1—colon cancer	4.35e-06	0.000143	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—PIK3CA—colon cancer	4.35e-06	0.000143	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—PIK3CA—colon cancer	4.33e-06	0.000143	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CTNNB1—colon cancer	4.33e-06	0.000143	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CDKN1A—colon cancer	4.33e-06	0.000143	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—PIK3CA—colon cancer	4.32e-06	0.000142	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CTNNB1—colon cancer	4.31e-06	0.000142	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—colon cancer	4.31e-06	0.000142	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—colon cancer	4.28e-06	0.000141	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—PIK3CA—colon cancer	4.28e-06	0.000141	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFB1—colon cancer	4.27e-06	0.000141	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—colon cancer	4.27e-06	0.000141	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CDKN1A—colon cancer	4.23e-06	0.000139	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—colon cancer	4.21e-06	0.000139	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CDKN1A—colon cancer	4.21e-06	0.000139	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EP300—colon cancer	4.21e-06	0.000139	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—colon cancer	4.19e-06	0.000138	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—colon cancer	4.18e-06	0.000138	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—colon cancer	4.13e-06	0.000136	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—EP300—colon cancer	4.12e-06	0.000136	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—colon cancer	4.12e-06	0.000136	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EP300—colon cancer	4.12e-06	0.000136	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—colon cancer	4.1e-06	0.000135	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—colon cancer	4.1e-06	0.000135	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—colon cancer	4.09e-06	0.000135	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SRC—colon cancer	4.09e-06	0.000135	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—colon cancer	4.03e-06	0.000133	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EP300—colon cancer	4.03e-06	0.000133	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—colon cancer	4.02e-06	0.000133	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—colon cancer	4.01e-06	0.000132	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EP300—colon cancer	4e-06	0.000132	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SRC—colon cancer	4e-06	0.000132	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—colon cancer	4e-06	0.000132	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—colon cancer	3.99e-06	0.000132	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—colon cancer	3.99e-06	0.000131	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—colon cancer	3.98e-06	0.000131	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—colon cancer	3.96e-06	0.00013	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—colon cancer	3.96e-06	0.00013	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—colon cancer	3.94e-06	0.00013	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NRAS—colon cancer	3.94e-06	0.00013	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—colon cancer	3.92e-06	0.000129	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SRC—colon cancer	3.91e-06	0.000129	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—colon cancer	3.91e-06	0.000129	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—colon cancer	3.9e-06	0.000129	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—colon cancer	3.9e-06	0.000128	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SRC—colon cancer	3.89e-06	0.000128	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—colon cancer	3.88e-06	0.000128	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—colon cancer	3.88e-06	0.000128	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—colon cancer	3.87e-06	0.000128	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—colon cancer	3.86e-06	0.000127	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—colon cancer	3.85e-06	0.000127	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—colon cancer	3.85e-06	0.000127	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—colon cancer	3.85e-06	0.000127	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—colon cancer	3.84e-06	0.000127	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—colon cancer	3.81e-06	0.000126	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—colon cancer	3.81e-06	0.000126	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—colon cancer	3.8e-06	0.000125	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—colon cancer	3.79e-06	0.000125	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—colon cancer	3.79e-06	0.000125	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—colon cancer	3.78e-06	0.000125	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—colon cancer	3.77e-06	0.000124	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—colon cancer	3.77e-06	0.000124	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—colon cancer	3.77e-06	0.000124	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—colon cancer	3.76e-06	0.000124	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—colon cancer	3.75e-06	0.000124	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—colon cancer	3.75e-06	0.000124	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—colon cancer	3.74e-06	0.000123	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—colon cancer	3.73e-06	0.000123	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—colon cancer	3.72e-06	0.000123	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—colon cancer	3.71e-06	0.000122	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—colon cancer	3.71e-06	0.000122	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—colon cancer	3.71e-06	0.000122	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—colon cancer	3.67e-06	0.000121	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—colon cancer	3.67e-06	0.000121	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—colon cancer	3.67e-06	0.000121	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—colon cancer	3.66e-06	0.000121	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—colon cancer	3.65e-06	0.000121	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—colon cancer	3.65e-06	0.00012	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—colon cancer	3.64e-06	0.00012	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—colon cancer	3.63e-06	0.00012	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—colon cancer	3.62e-06	0.000119	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—colon cancer	3.62e-06	0.000119	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—colon cancer	3.59e-06	0.000118	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—colon cancer	3.59e-06	0.000118	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—colon cancer	3.59e-06	0.000118	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—colon cancer	3.58e-06	0.000118	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—colon cancer	3.56e-06	0.000117	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—colon cancer	3.55e-06	0.000117	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—colon cancer	3.55e-06	0.000117	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—colon cancer	3.54e-06	0.000117	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—colon cancer	3.54e-06	0.000117	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—colon cancer	3.54e-06	0.000117	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—colon cancer	3.53e-06	0.000117	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—colon cancer	3.53e-06	0.000116	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—colon cancer	3.52e-06	0.000116	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—colon cancer	3.51e-06	0.000116	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—colon cancer	3.51e-06	0.000116	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—colon cancer	3.51e-06	0.000116	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—colon cancer	3.5e-06	0.000115	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—colon cancer	3.49e-06	0.000115	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—colon cancer	3.49e-06	0.000115	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—colon cancer	3.48e-06	0.000115	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TYMS—colon cancer	3.48e-06	0.000115	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—colon cancer	3.48e-06	0.000115	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—colon cancer	3.47e-06	0.000115	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—colon cancer	3.47e-06	0.000114	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.47e-06	0.000114	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—colon cancer	3.46e-06	0.000114	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—colon cancer	3.45e-06	0.000114	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—colon cancer	3.44e-06	0.000113	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—colon cancer	3.43e-06	0.000113	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—colon cancer	3.41e-06	0.000113	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—colon cancer	3.41e-06	0.000113	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—colon cancer	3.39e-06	0.000112	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—colon cancer	3.38e-06	0.000112	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—colon cancer	3.37e-06	0.000111	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—colon cancer	3.36e-06	0.000111	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—colon cancer	3.36e-06	0.000111	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—colon cancer	3.35e-06	0.000111	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—colon cancer	3.35e-06	0.00011	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—colon cancer	3.32e-06	0.000109	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—colon cancer	3.31e-06	0.000109	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—colon cancer	3.31e-06	0.000109	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—colon cancer	3.3e-06	0.000109	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—colon cancer	3.29e-06	0.000109	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—colon cancer	3.29e-06	0.000108	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—colon cancer	3.28e-06	0.000108	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—colon cancer	3.27e-06	0.000108	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—colon cancer	3.25e-06	0.000107	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—colon cancer	3.25e-06	0.000107	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—colon cancer	3.25e-06	0.000107	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—colon cancer	3.24e-06	0.000107	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—colon cancer	3.24e-06	0.000107	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—colon cancer	3.23e-06	0.000107	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—colon cancer	3.23e-06	0.000106	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—colon cancer	3.22e-06	0.000106	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—colon cancer	3.22e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—colon cancer	3.19e-06	0.000105	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—colon cancer	3.19e-06	0.000105	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—colon cancer	3.15e-06	0.000104	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—colon cancer	3.11e-06	0.000103	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—colon cancer	3.1e-06	0.000102	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—colon cancer	3.08e-06	0.000102	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—colon cancer	3.07e-06	0.000101	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—colon cancer	3.05e-06	0.000101	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—colon cancer	3.05e-06	0.0001	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—colon cancer	3.03e-06	9.99e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—colon cancer	3.02e-06	9.97e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—colon cancer	3.02e-06	9.97e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—colon cancer	3.02e-06	9.95e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—colon cancer	3.01e-06	9.94e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—colon cancer	3.01e-06	9.93e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—colon cancer	3.01e-06	9.93e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—colon cancer	3.01e-06	9.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—colon cancer	3e-06	9.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—colon cancer	3e-06	9.88e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—colon cancer	2.98e-06	9.82e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—colon cancer	2.98e-06	9.81e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—colon cancer	2.97e-06	9.79e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—colon cancer	2.97e-06	9.79e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—colon cancer	2.96e-06	9.78e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—colon cancer	2.96e-06	9.77e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—colon cancer	2.96e-06	9.77e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—colon cancer	2.96e-06	9.75e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—colon cancer	2.95e-06	9.72e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—colon cancer	2.95e-06	9.71e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—colon cancer	2.94e-06	9.69e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—colon cancer	2.91e-06	9.6e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—colon cancer	2.89e-06	9.54e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—colon cancer	2.88e-06	9.5e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—colon cancer	2.88e-06	9.5e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—colon cancer	2.87e-06	9.45e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—colon cancer	2.85e-06	9.38e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—colon cancer	2.82e-06	9.29e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—colon cancer	2.8e-06	9.23e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—colon cancer	2.79e-06	9.21e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—colon cancer	2.79e-06	9.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—colon cancer	2.78e-06	9.15e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—colon cancer	2.76e-06	9.08e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—colon cancer	2.75e-06	9.07e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—colon cancer	2.74e-06	9.04e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—colon cancer	2.7e-06	8.9e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—colon cancer	2.68e-06	8.84e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—colon cancer	2.66e-06	8.76e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—colon cancer	2.62e-06	8.65e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—colon cancer	2.62e-06	8.63e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—colon cancer	2.61e-06	8.62e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—colon cancer	2.57e-06	8.48e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—colon cancer	2.57e-06	8.48e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—colon cancer	2.57e-06	8.46e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—colon cancer	2.56e-06	8.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—colon cancer	2.55e-06	8.41e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—colon cancer	2.54e-06	8.39e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—colon cancer	2.53e-06	8.34e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—colon cancer	2.53e-06	8.33e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—colon cancer	2.51e-06	8.28e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—colon cancer	2.49e-06	8.22e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—colon cancer	2.49e-06	8.21e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—colon cancer	2.49e-06	8.2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—colon cancer	2.48e-06	8.19e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—colon cancer	2.48e-06	8.16e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—colon cancer	2.47e-06	8.14e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—colon cancer	2.47e-06	8.13e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—colon cancer	2.46e-06	8.12e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—colon cancer	2.44e-06	8.06e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—colon cancer	2.43e-06	8.02e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—colon cancer	2.42e-06	7.98e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—colon cancer	2.42e-06	7.98e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—colon cancer	2.38e-06	7.85e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—colon cancer	2.37e-06	7.83e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—colon cancer	2.37e-06	7.81e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—colon cancer	2.36e-06	7.78e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—colon cancer	2.34e-06	7.71e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—colon cancer	2.14e-06	7.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—colon cancer	2.14e-06	7.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—colon cancer	2.1e-06	6.93e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—colon cancer	2.1e-06	6.92e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—colon cancer	2.1e-06	6.91e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—colon cancer	2.09e-06	6.89e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—colon cancer	2.09e-06	6.89e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—colon cancer	2.08e-06	6.87e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—colon cancer	2.06e-06	6.8e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—colon cancer	1.98e-06	6.54e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—colon cancer	1.94e-06	6.39e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—colon cancer	1.94e-06	6.38e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.82e-06	6.01e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—colon cancer	1.62e-06	5.34e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—colon cancer	1.61e-06	5.32e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—colon cancer	1.58e-06	5.21e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.55e-06	5.09e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—colon cancer	1.49e-06	4.91e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—colon cancer	1.26e-06	4.16e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.19e-06	3.93e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—colon cancer	9.74e-07	3.21e-05	CbGpPWpGaD
